Dexamethasone Alternatives Compared
Dexamethasone | Nucala (mepolizumab) | Xolair (omalizumab) |
|
---|
Dexamethasone | Nucala (mepolizumab) | Xolair (omalizumab) |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Dexamethasone reduces inflammation and calms down an overactive immune system and is significantly more potent than prednisolone. It may be given to control inflammation associated with eye disease... View more |
Prescription only
Nucala is a biologic that works by blocking the action of IL-5 which is the main cytokine responsible for the survival and production of eosinophils. Nucala may be used to treat severe eosinophilic... View more |
Prescription only
Xolair is an injectable preparation that works by preventing IgE from binding to IgE receptors on mast cells and basophils and may be used to treat allergic asthma, nasal polyps, chronic idiopathic... View more |
Related suggestions |
|||||||||||||||
More about Dexamethasone | More about Nucala (mepolizumab) | More about Xolair (omalizumab) | ||||||||||||||||
Ratings & Reviews | ||||||||||||||||||
Dexamethasone has an average rating of 5.9 out of 10 from a total of 164 ratings on Drugs.com. 46% of reviewers reported a positive effect, while 35% reported a negative effect. |
Nucala has an average rating of 7.3 out of 10 from a total of 100 ratings on Drugs.com. 60% of reviewers reported a positive effect, while 16% reported a negative effect. |
Xolair has an average rating of 7.5 out of 10 from a total of 229 ratings on Drugs.com. 67% of reviewers reported a positive effect, while 18% reported a negative effect. |
||||||||||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||
View all Dexamethasone side effects |
View all Nucala side effects |
View all Xolair side effects |
||||||||||||||||
Drug Class | ||||||||||||||||||
Generic Availability | ||||||||||||||||||
Lower cost generic |
N/A |
N/A |
||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
View all Dexamethasone prices |
View all Nucala prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||||||||||
Dosage Forms | ||||||||||||||||||
|
|
|
||||||||||||||||
Brand Names | ||||||||||||||||||
De-Sone LA, Dexabliss, Dexamethasone Intensol, Dxevo, Hemady, HiDex, TaperDex, Zcort, ZoDex View more |
N/A |
Other omalizumab brands include: Omlyclo | ||||||||||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||
N/A |
528 hours |
624 hours |
||||||||||||||||
CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category | ||||||||||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category N
Not classified
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | ||||||||||||||||||
A total of 824 drugs are known to interact with Dexamethasone:
|
A total of 25 drugs are known to interact with Nucala:
|
A total of 31 drugs are known to interact with Xolair:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
Disease Interactions | ||||||||||||||||||
|
||||||||||||||||||
First Approval Date | ||||||||||||||||||
October 30, 1958 |
November 04, 2015 |
June 20, 2003 |
||||||||||||||||
WADA Class View classifications | ||||||||||||||||||
N/A |
N/A |
|||||||||||||||||
More Information | ||||||||||||||||||
Patient Resources | ||||||||||||||||||
Professional Resources | ||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||
|
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Entyvio
Entyvio (vedolizumab) is used to treat ulcerative colitis (UC) and Crohn's disease, reducing ...
Benlysta
Benlysta is used to treat active systemic lupus erythematosus (SLE) and active lupus nephritis. It ...
Dupixent
Dupixent is used to treat eczema, eosinophilic or oral-corticosteroid-dependent asthma, chronic ...
Carvykti
Carvykti (ciltacabtagene autoleucel) is a treatment for relapsed or refractory multiple myeloma ...
Abecma
Abecma is a CAR T cell therapy used to treat relapsed refractory multiple myeloma (RRMM); it is a ...
Nplate
Nplate is used to prevent bleeding episodes in people with chronic immune thrombocytopenic purpura ...
Otezla
Otezla (apremilast) is used to treat plaque psoriasis, psoriatic arthritis, and oral ulcers ...
Saphnelo
Saphnelo is used for moderate to severe SLE (lupus) for adults who are also receiving other lupus ...
Skyrizi
Skyrizi (risankizumab) is used to treat plaque psoriasis, psoriatic arthritis, ulcerative colitis ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.